Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice

European Journal of Pharmacology

Volumn 689, Issue 1-3, 2012, Pages 96-103

  Fitting, Sylvia ^a   Scoggins, Krista L ^a   Xu, Ruqiang ^a   Dever, Seth M ^a   Knapp, Pamela E ^a   Dewey, William L ^a   Hauser, Kurt F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Neuro acquired immunodeficiency syndrome (neuroAIDS); Nociception; Opioid drug abuse; Spinal cord; Striatum

Indexed keywords

MESSENGER RNA; MORPHINE SULFATE; PLACEBO; TRANSACTIVATOR PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG RESPONSE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HIV ASSOCIATED DEMENTIA; HOT PLATE TEST; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MOTOR PERFORMANCE; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPONSE TIME; ROTAROD TEST; SPINAL CORD; TAIL FLICK TEST; TASK PERFORMANCE; TAT GENE; TRANSGENIC MOUSE; VIRUS LOAD;

ANIMALS; BEHAVIOR, ANIMAL; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHINE; PAIN MEASUREMENT; SPINAL CORD; TREATMENT OUTCOME;

EID: 84864277477     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.05.029     Document Type: Article

References (87)

1. M.W. Adler, E.B. Geller, T.J. Rogers, E.E. Henderson, and T.K. Eisenstein Opioids, receptors, and immunity Adv. Exp. Med. Biol. 335 1993 13 20 (Pubitemid 23294289)
2. I.C. Anthony, J.C. Arango, B. Stephens, P. Simmonds, and J.E. Bell The effects of illicit drugs on the HIV infected brain Front. Biosci. 13 2008 1294 1307 (Pubitemid 351594711)
3. I.C. Anthony, S.N. Ramage, F.W. Carnie, P. Simmonds, and J.E. Bell Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection? Neuropathol. Appl Neurobiol. 31 2005 325 338 (Pubitemid 40769531)
4. J.D. Barks, X.H. Liu, R. Sun, and F.S. Silverstein gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats Neuroscience 76 1997 397 409 (Pubitemid 27008471)
5. J.E. Bell, J.C. Arango, and I.C. Anthony Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs J. Neuroimmune Pharmacol. 1 2006 182 191 (Pubitemid 44257492)
6. J.E. Bell, R.P. Brettle, A. Chiswick, and P. Simmonds HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement Brain 121 Pt 11 1998 2043 2052 (Pubitemid 28497903)
7. J.R. Berger, and A. Nath HIV dementia and the basal ganglia Intervirology 40 1997 122 131 (Pubitemid 28021606)
8. R. Brack-Werner Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis AIDS 13 1999 1 22
9. D.E. Brenneman, G.L. Westbrook, S.P. Fitzgerald, D.L. Ennist, K.L. Elkins, M.R. Ruff, and C.B. Pert Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide Nature 335 1988 639 642
10. A.J. Bruce-Keller, J. Turchan-Cholewo, E.J. Smart, T. Geurin, A. Chauhan, R. Reid, R. Xu, A. Nath, P.E. Knapp, and K.F. Hauser Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice Glia 56 2008 1414 1427
11. D.A. Byrd, R.P. Fellows, S. Morgello, D. Franklin, R.K. Heaton, R. Deutsch, J.H. Atkinson, D.B. Clifford, A.C. Collier, C.M. Marra, B. Gelman, J.A. McCutchan, N.A. Duarte, D.M. Simpson, J. McArthur, and I. Grant Neurocognitive impact of substance use in HIV infection J. Acquir. Immune Defic. Syndr. 58 2011 154 162
12. A.J. Cann, J.D. Rosenblatt, W. Wachsman, N.P. Shah, and I.S. Chen Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation Nature 318 1985 571 574 (Pubitemid 16173046)
13. D.J. Carr, and M. Serou Exogenous and endogenous opioids as biological response modifiers Immunopharmacology 31 1995 59 71
14. S.L. Chang, J.A. Beltran, and S. Swarup Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model J. Virol. 81 2007 8406 8411 (Pubitemid 47242814)
15. Chang, S.L.; Connaghan, K.P.; 2012. Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J. Neuroimmune Pharmacol. 7, 332-340.
16. S.L. Chang, and M. Vigorito Role of HIV-1 infection in addictive behavior: a study of a HIV-1 transgenic rat model Am J. Infect. Dis. 2 2006 98 106
17. X. Chen, L.G. Kirby, J. Palma, K. Benamar, E.B. Geller, T.K. Eisenstein, and M.W. Adler The effect of gp120 on morphines antinociceptive and neurophysiological actions Brain Behav. Immunol. 25 2011 1434 1443
18. J. Cochin Methods of the appraisal of analgetic drugs for addiction liability A. Burger, Selected Pharmacological Testing Methods 1968 Marcel Dekker New York 121 167
19. L. Del Valle, S. Croul, S. Morgello, S. Amini, J. Rappaport, and K. Khalili Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy J. Neurovirol. 6 2000 221 228 (Pubitemid 30447166)
20. S.M. Dever, R. Xu, S. Fitting, P.E. Knapp, and K.F. Hauser Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types J. Neurovirol 18 2012 181 190
21. W.L. Dewey, L.S. Harris, J.F. Howes, and J.A. Nuite The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests J. Pharmacol. Exp. Ther. 175 1970 435 442
22. i, NF-κB trafficking and transcription PLoS One 3 2008 e4093
23. 2, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat Glia 50 2005 91 106 (Pubitemid 40695264)
24. N. El-Hage, G. Wu, J. Ambati, A.J. Bruce-Keller, P.E. Knapp, and K.F. Hauser CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates J. Neuroimmunol. 178 2006 9 16 (Pubitemid 44307341)
25. N. El-Hage, G. Wu, J. Wang, J. Ambati, P.E. Knapp, J.L. Reed, A.J. Bruce-Keller, and K.F. Hauser HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines Glia 53 2006 132 146
26. B. Ensoli, L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R.A. Morgan, P. Wingfield, and R.C. Gallo Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J. Virol. 67 1993 277 287 (Pubitemid 23002988)
27. B. Ensoli, V. Fiorelli, F. Ensoli, A. Cafaro, F. Titti, S. Butto, P. Monini, M. Magnani, A. Caputo, and E. Garaci Candidate HIV-1 Tat vaccine development: from basic science to clinical trials AIDS 20 2006 2245 2261 (Pubitemid 44789527)
28. M.J. Ferris, C.F. Mactutus, and R.M. Booze Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS Neurosci. Biobehav. Rev. 32 2008 883 909
29. S. Fitting, R. Xu, C. Bull, S.K. Buch, N. El-Hage, A. Nath, P.E. Knapp, and K.F. Hauser Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons Am. J. Pathol. 177 2010 1397 1410
30. S. Fitting, S. Zou, W. Chen, P. Vo, K.F. Hauser, and P.E. Knapp Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis J. Proteome Res. 9 2010 1795 1804
31. B.B. Gelman, J.A. Spencer, C.E. Holzer 3rd, and V.M. Soukup Abnormal striatal dopaminergic synapses in National NeuroAIDS tissue consortium subjects with HIV encephalitis J. Neuroimmune Pharmacol. 1 2006 410 420 (Pubitemid 44786674)
32. K. Goodkin, F.L. Wilkie, M. Concha, D. Asthana, P. Shapshak, R. Douyon, R.K. Fujimura, and C. LoPiccolo Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates Neuroimaging Clin. N. Am. 7 1997 561 579 (Pubitemid 27434587)
33. P.R. Gorry, C. Ong, J. Thorpe, S. Bannwarth, K.A. Thompson, A. Gatignol, S.L. Vesselingh, and D.F. Purcell Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia Curr. HIV Res. 1 2003 463 473
34. J.A. Gurwell, A. Nath, Q. Sun, J. Zhang, K.M. Martin, Y. Chen, and K.F. Hauser Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro Neuroscience 102 2001 555 563 (Pubitemid 32171876)
35. B. Haelewyn, T. Freret, E. Pacary, P. Schumann-Bard, M. Boulouard, M. Bernaudin, and V. Bouet Long-term evaluation of sensorimotor and mnesic behaviour following striatal NMDA-induced unilateral excitotoxic lesion in the mouse Behav. Brain Res. 178 2007 235 243 (Pubitemid 46341441)
36. L.S. Harris, and A.K. Pierson Some narcotic antagonists in the benzomorphan series J. Pharmacol. Exp. Ther. 143 1964 141 148
37. K.F. Hauser, N. El-Hage, S. Buch, J.R. Berger, W.R. Tyor, A. Nath, A.J. Bruce-Keller, and P.E. Knapp Molecular targets of opiate drug abuse in neuroAIDS Neurotox. Res. 8 2005 63 80
38. K.F. Hauser, N. El-Hage, A. Stiene-Martin, W.F. Maragos, A. Nath, Y. Persidsky, D.J. Volsky, and P.E. Knapp HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse J. Neurochem. 100 2007 567 586 (Pubitemid 46095610)
39. S. Hu, W.S. Sheng, J.R. Lokensgard, and P.K. Peterson Morphine potentiates HIV-1 gp120-induced neuronal apoptosis J. Infect. Dis. 191 2005 886 889 (Pubitemid 40349803)
40. G.J. Jones, N.L. Barsby, E.A. Cohen, J. Holden, K. Harris, P. Dickie, J. Jhamandas, and C. Power HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration J. Neurosci. 27 2007 3703 3711 (Pubitemid 46557688)
41. M. Jones, K. Olafson, M.R. Del Bigio, J. Peeling, and A. Nath Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement J. Neuropathol. Exp. Neurol. 57 1998 563 570
42. M.V. Jones, J.E. Bell, and A. Nath Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia AIDS 14 2000 2709 2713 (Pubitemid 32118724)
43. L.R. Kimball, and W.C. McCormick The pharmacologic management of pain and discomfort in persons with AIDS near the end of life: use of opioid analgesia in the hospice setting J. Pain Symptom Manage. 11 1996 88 94 (Pubitemid 26073494)
44. J. Koeppe, C. Armon, K. Lyda, C. Nielsen, and S. Johnson Ongoing pain despite aggressive opioid pain management among persons with HIV Clin. J. Pain 26 2010 190 198
45. J. Koeppe, K. Lyda, S. Johnson, and C. Armon Variables associated with decreasing pain among persons living with human immunodeficiency virus: a longitudinal follow-up study Clin. J. Pain 28 2012 32 38
46. S. Kramer-Hammerle, I. Rothenaigner, H. Wolff, J.E. Bell, and R. Brack-Werner Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus Virus Res. 111 2005 194 213 (Pubitemid 40909736)
47. H.G. Kress, and B. Kraft Opioid medication and driving ability Eur. J. Pain 9 2005 141 144 (Pubitemid 40311834)
48. A.M. Kumar, R.L. Ownby, D. Waldrop-Valverde, B. Fernandez, and M. Kumar Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance J. Neurovirol. 17 2011 26 40
49. L. Langerman, M.I. Zakowski, B. Piskoun, and G.J. Grant Hot plate versus tail flick: evaluation of acute tolerance to continuous morphine infusion in the rat model J. Pharmacol. Toxicol. Methods 34 1995 23 27
50. J.L. Laprairie, M.E. Johns, and A.Z. Murphy Preemptive morphine analgesia attenuates the long-term consequences of neonatal inflammation in male and female rats Pediatr. Res. 64 2008 625 630
51. A.L. Lashomb, M. Vigorito, and S.L. Chang Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat J. Neurovirol. 15 2009 14 24
52. M. Lefkowitz, and I. Grant Pain management in HIV infection H.E. Gendelman, I. Grant, I.P. Everall, S.A. Lipton, S. Swindells, The Neurology of AIDS 2005 Oxford University Press Oxford 811 819
53. J.C. Li, H.C. Yim, and A.S. Lau Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection AIDS 24 2010 1609 1623
54. X. Lin, D. Irwin, S. Kanazawa, L. Huang, J. Romeo, T.S. Yen, and B.M. Peterlin Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir J. Virol. 77 2003 8227 8236 (Pubitemid 36871450)
55. S.B. Maggirwar, N. Tong, S. Ramirez, H.A. Gelbard, and S. Dewhurst HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity J. Neurochem. 73 1999 578 586 (Pubitemid 29339830)
56. D.S. Magnuson, B.E. Knudsen, J.D. Geiger, R.M. Brownstone, and A. Nath Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity Ann. Neurol. 37 1995 373 380
57. K. Mizoguchi, M. Yuzurihara, A. Ishige, M. Aburada, and T. Tabira Saiko-ka-ryukotsu-borei-to, a herbal medicine, ameliorates chronic stress-induced depressive state in rotarod performance Pharmacol. Biochem. Behav. 75 2003 419 425 (Pubitemid 36859828)
58. A. Nath Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia J. Infect. Dis. 186 Suppl 2 2002 S193 198
59. A. Nath, C. Anderson, M. Jones, W. Maragos, R. Booze, C. Mactutus, J. Bell, K.F. Hauser, and M. Mattson Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia J. Psychopharmacol. 14 2000 222 227
60. A. Nath, K. Conant, P. Chen, C. Scott, and E.O. Major Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon J. Biol. Chem. 274 1999 17098 17102
61. J.P. OCallaghan, and S.G. Holtzman Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure J. Pharmacol. Exp. Ther. 192 1975 497 505
62. J. Palma, A. Cowan, E.B. Geller, M.W. Adler, and K. Benamar Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120 Drug Alcohol Depend. 118 2011 497 499
63. H.K. Patton, E.N. Benveniste, and D.J. Benos Astrocytes and the AIDS dementia complex J. NeuroAIDS 1 1996 111 131 (Pubitemid 26040740)
64. S.W. Perry, J. Barbieri, N. Tong, O. Polesskaya, S. Pudasaini, A. Stout, R. Lu, M. Kiebala, S.B. Maggirwar, and H.A. Gelbard Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax J. Neurosci. 30 2010 14153 14164
65. A. Pertovaara, and M.M. Hamalainen Spinal potentiation and supraspinal additivity in the antinociceptive interaction between systemically administered alpha 2-adrenoceptor agonist and cocaine in the rat Anesth. Analg. 79 1994 261 266 (Pubitemid 24240861)
66. P.K. Peterson, T.W. Molitor, and C.C. Chao The opioid-cytokine connection J. Neuroimmunol. 83 1998 63 69 (Pubitemid 28280952)
67. V. Philippon, C. Vellutini, D. Gambarelli, G. Harkiss, G. Arbuthnott, D. Metzger, R. Roubin, and P. Filippi The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines Virology 205 1994 519 529
68. Podhaizer, E.M.; Zou, S.; Fitting, S.; Samano, K.L.; El-Hage, N.; Knapp, P.E.; Hauser, K.F.; 2011. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. J. Neuroimmune Pharmacol, DOI 10.1007/s11481-011-9326-z.
69. F. Porreca, H.I. Mosberg, J.R. Omnaas, T.F. Burks, and A. Cowan Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test J. Pharmacol. Exp. Ther. 240 1987 890 894 (Pubitemid 17043590)
70. Proudnikov, D.; Randesi, M.; Orna, L.; Crystal, H.; Dorn, M.; Ott, J.; Ho, A.; Kreek, M.J.; 2012. Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. J. Infect. Dis. 205, 1745-1756.
71. J. Robinson-Papp, B.B. Gelman, I. Grant, E. Singer, G. Gensler, and S. Morgello Substance abuse increases the risk of neuropathy in an HIV-infected cohort Muscle Nerve 45 2012 471 476
72. Rogers, D.C.; Campbell, C.A.; Stretton, J.L.; Mackay, K.B.; 1997. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28, 2060-2065; discussion 2066.
73. T.J. Rogers, and P.K. Peterson Opioid G protein-coupled receptors: signals at the crossroads of inflammation Trends Immunol. 24 2003 116 121 (Pubitemid 36263094)
74. J.M. Sabatier, E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, and E. Bahraoui Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 J. Virol. 65 1991 961 967
75. H. Saito Inhibitory and stimulatory effects of morphine on locomotor activity in mice: biochemical and behavioral studies Pharmacol. Biochem. Behav. 35 1990 231 235 (Pubitemid 20034591)
76. C.D. Sarantopoulos Advances in the therapy of cancer pain: from novel experimental models to evidence-based treatments Signa Vitae 2 2007 S23 41
77. H. Shiotsuki, K. Yoshimi, Y. Shimo, M. Funayama, Y. Takamatsu, K. Ikeda, R. Takahashi, S. Kitazawa, and N. Hattori A rotarod test for evaluation of motor skill learning J. Neurosci. Methods 189 2010 180 185
78. L.J. Sim-Selley, K.L. Scoggins, M.P. Cassidy, L.A. Smith, W.L. Dewey, F.L. Smith, and D.E. Selley Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance Br. J. Pharmacol. 151 2007 1324 1333 (Pubitemid 47255897)
79. S.M. South, and M.T. Smith Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats J. Pharmacol. Exp Ther. 286 1998 1326 1332 (Pubitemid 29135547)
80. S. Theodore, W.A. Cass, A. Nath, and W.F. Maragos Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration Curr. HIV Res. 5 2007 301 313 (Pubitemid 46785066)
81. S.M. Toggas, E. Masliah, E.M. Rockenstein, G.F. Rall, C.R. Abraham, and L. Mucke Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice Nature 367 1994 188 193 (Pubitemid 24031702)
82. C. Tornatore, K. Meyers, W. Atwood, K. Conant, and E. Major Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes J. Virol. 68 1994 93 102
83. J. Turchan-Cholewo, F.O. Dimayuga, Q. Ding, J.N. Keller, K.F. Hauser, P.E. Knapp, and A.J. Bruce-Keller Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia J. Neurosci. Res. 86 2008 2100 2110
84. J. Turchan-Cholewo, Y. Liu, S. Gartner, R. Reid, C. Jie, X. Peng, K.C. Chen, A. Chauhan, N. Haughey, R. Cutler, M.P. Mattson, C. Pardo, K. Conant, N. Sacktor, J.C. McArthur, K.F. Hauser, C. Gairola, and A. Nath Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl Neurobiol. Dis. 23 2006 109 119 (Pubitemid 43922460)
85. L. Vitkovic, and A. da Cunha Role for astrocytosis in HIV-1-associated dementia Curr. Top. Microbiol. Immunol. 202 1995 105 116
86. Z. Wang, G. Trillo-Pazos, S.Y. Kim, M. Canki, S. Morgello, L.R. Sharer, H.A. Gelbard, Z.Z. Su, D.C. Kang, A.I. Brooks, P.B. Fisher, and D.J. Volsky Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis J. Neurovirol. 10 Suppl 1 2004 25 32 (Pubitemid 38325090)
87. S. Zou, S. Fitting, Y.K. Hahn, S.P. Welch, N. El-Hage, K.F. Hauser, and P.E. Knapp Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at mu-opioid receptor-expressing glia Brain 134 2011 3616 3631